Bloomsbury Bioseed Fund

Based on its name and self-description, the fund invests at the seed stage in biosecurity-related life sciences. Likely targets include agricultural biosecurity, zoonotic disease surveillance, crop genetics and veterinary biologics. All investments are expected to originate from UK research ecosystems.

No public data on fund size, total deployment or team size is available. The firm has not published any AUM or committed capital figure, and no portfolio company has named it in a publicly available announcement. Its absence from standard databases suggests it is either a small vehicle, newly launched, or an exploratory effort.

The firm's name and London location suggest close ties to the Bloomsbury research cluster, which includes University College London, the Francis Crick Institute and the London School of Hygiene & Tropical Medicine. Deal flow likely depends on personal relationships with principal investigators and technology transfer offices within the University of London federation.

No co-investment activity has been publicly recorded. If the fund operates as described, it would typically write pre-institutional seed cheques ahead of larger life sciences VCs, who might follow in later rounds. But no specific co-investors or syndicates have been named in any traceable source.

There is no public evidence confirming current activity. The firm has no known website, no LinkedIn presence, no regulatory filings naming it as an active investment vehicle, and no portfolio companies attributing funding to it. Based on available information, its operational status cannot be verified.